Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 63 of 95, showing 5 Applications out of 471 total, starting on record 311, ending on 315

# Protocol No Study Title Investigator(s) & Site(s)

311.

ECCT/22/09/02   LISA Trial
    Levonorgestrel intrauterine system effects on hemoglobin and serum ferritin among anemic women in Kenya: An open label randomized trial to compare with an oral contraceptive regimen that provides supplemental ferrous fumarate tablets   
Principal Investigator(s)
1. Faith Mugure Thuita
Site(s) in Kenya
Kangemi Health Centre
 
View

312.

ECCT/12/10/01   REMEMBER STUDY
    Reducing Early Mortality and Early Morbidity by Empiric Tuberculosis Treatment Regimens   
Principal Investigator(s)
1. Lucy N/A Koech
Site(s) in Kenya
1. KEMRI/WRP Kericho (Kericho county)
2. AMPATH Moi University Eldoret (Kericho county)
 
View

313.

ECCT/23/04/05   BiMVaC01
    A randomised, controlled clinical trial to assess and compare the immunogenicity, safety and reactogenicity of the bivalent Omicron BA.4/BA.5 adapted, and the original Wuhan-Hu-1-strain, BNT162b2 COVID-19 vaccine formulations in healthy unvaccinated East African adults.   
Principal Investigator(s)
1. NDUNGU FRANCIS
2. Said Jongo
Site(s) in Kenya
KEMRI-CGMRC Kilifi
 
View

314.

ECCT/15/02/03   IVERMAL study
    Efficacy and safety of high-dose Ivermectin for reducing malaria transmission: A dose finding study   
Principal Investigator(s)
1. Menno Roderick Smit
Site(s) in Kenya
1. Jaramogi Oginga Odinga Teaching and Referral Hospital (JOOTRH) (Kisumu county)
2. Kisumu District Hospital (KDH), (Kisumu county)
3. Siaya District Hospital (Siaya county)
4. Vihiga District Hospital (Vihiga county)
 
View

315.

ECCT/11/12/04   PENNVAX-G DNA/MVA HIV Vaccine Phase 1 trial
    A Phase I Study of the Safety and Immunogenicity of PENNVAX™-G DNA (Env & Gag) Administered by Intramuscular Biojector® 2000 or by CELLECTRA® Intramuscular Electroporation Device Followed by MVACMDR (HIV-1 CM235 env/ CM240 gag/pol) Boost in Healthy, HIV Uninfected Adults   
Principal Investigator(s)
1. FREDRICK KIPYEGO SAWE
Site(s) in Kenya
KEMRI/Walter Reed Project-Kericho
 
View